Study Group: Renagel Prescribers for Chronic Renal Failure (US)(?)
Council Members in this Study Group: 18
Request a survey with this Study Group
Leading Experts in this Study Group
Medical Director
Davita Los Angeles Dialysis Center
Jack Rubin, MD, is Medical Director of the Los Angeles Vascular Access Center (LAVAC) in Inglewood, California. LAVAC does out patient procedures to correct problems with vascular accesses in dialysis patients. LAVAC also does out-patient angiograms of the legs and repairs stenoses of femoral arteries...
Medical Director
Dva Renal Healthcare, Inc.
Edward Littman, MD, is the Medical Director of the Davita Dialysis Clinics in Norwalk, Connecticut. He also serves as a Clinical Associate Professor of Medicine at the Yale University School of Medicine. Dr. Littman’s major area of expertise is in dialysis treatment of chronic kidney disease. He was...
Partner
Nephrology Associates of Montgomery County
Jeffrey Perlmutter, MD, is a Nephrologist in private practice in Maryland. He has experience in the treatment of all forms of acute and chronic kidney disease including the care of patients with end stage renal disease requiring dialysis or transplantation. He is the Medical Director of a hospital-based...
Clinical Associate Professor
Michigan State University
Andrew Krutul, MD, is a Nephrologist at the Renal Associates of western Michigan in Grand Rapids Michigan. He served for years as a Clinical Section Chief of Nephrology at St Mary's Mercy Medical Center and serves as a Clinical Associate Professor at the Michigan State University School of Medicine....
Related Study Groups
GLG NewsSMAnalyses by this Study Group's Leading Experts(?)
While no more would argue that control of systolic hypertension is crucial to preventing the consequences of hypertension such as congestive heart failure, MI's, left ventricular hyperthrophy, stroke and kidney failure there are other factors that are associated with these disease states. One of these...
This article brings more visibility to issue of effect of angiogenesis inhibitors on kidney function Other mechanisms of injury have previously been described. Current case simply adds visibility and more definitive evidence of effect in humans Mechanism described is likely not restricted...
Ferumoxytol is not likely to gain market share and widespread use by hemodialysis centers. This new iron preparation offers no benefit over Ferrlecit and Venofer. Additionally, hemodialysis patient's are not inconvenienced by 30 minute infusion versus a 5-minute infusion.
DDAVP reduces urine output and is useful in the treatment of bedwetting (enuresis). However the reduction in excretion of water can be associated with water intoxication (hyponatremia). FDA advises that DDAVP is no longer considered indicated for the treatment of enuresis.
Extended Release niacin has the second highest discontinuation rate. Laropiprant is a selective antagonist of the prostaglandin D(2) receptor subtype 1, which reduces niacin-induced vasodilation. Is it better than Aspirin?!
Most Common Company Types:
- Academic Medical Center/Hospital or Clinic
- Office Based Private Practice or Clinic
- Government/Military Hospital or Clinic
- Other Freestanding Healthcare Facility
- Non-Academic Community Hospital or Clinic
- Non-profit organization
Most Common Job Types:
- Physician - Attending Physician
- Medical Director
- Physician - Division Head
- Chief Executive Officer
- Owner
- Physician - Director
- Director
- Partner
GLG's 750+ Clients Include:
global mutual funds
global banks
private equity firms